Insiders · DGX

J. E. Davis

CEO and President, Director at Quest Diagnostics Inc (DGX)

J. E. Davis has filed 24 insider reports with the SEC since February 2021, as CEO and President and director at Quest Diagnostics Inc (DGX). In the last 12 months J. E. Davis sold $17.1M of stock on the open market. In the latest filing, on September 3, 2026, J. E. Davis sold 10,000 shares of Quest Diagnostics Inc (DGX) for $2.43M at an average of $242.72.

Filings
24
Companies
1
Bought on market
None
Sold on market
$23.7M

Companies where J. E. Davis is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Quest Diagnostics Inc logo
DGX
Quest Diagnostics Inc
CEO and President, Director122,423$23.7M$259.69Sep 3, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare J. E. Davis with

Other insiders at the same companies

Questions about J. E. Davis

What is J. E. Davis's role at Quest Diagnostics Inc?
J. E. Davis reports to the SEC as CEO and President and director at Quest Diagnostics Inc (DGX), according to the latest filing on September 3, 2026.
How many shares does J. E. Davis own?
After the latest filing that states it, J. E. Davis directly owned 122,423 shares of Quest Diagnostics Inc (DGX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has J. E. Davis bought or sold stock recently?
The most recent open-market sale was on September 1, 2026: sold 10,000 shares of Quest Diagnostics Inc (DGX) for $2.43M at an average of $242.72.
How do I get alerts when J. E. Davis files?
Follow J. E. Davis on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. J. E. Davis filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by J. E. Davis (SEC CIK 0001599837). Totals count each trade once, skipping amendments whose original is on file, from Feb 20, 2021 on. View on SEC EDGAR